Phase 2 Multi‐Arm Study of Magrolimab Combinations in Patients With Acute Myeloid Leukaemia
ABSTRACT Introduction This phase 2 study evaluated magrolimab+venetoclax (VEN)+azacitidine (AZA) in untreated, unfit acute myeloid leukaemia (AML) and magrolimab+mitoxantrone+etoposide+cytarabine in relapsed/refractory (R/R) AML. Methods Endpoints included complete remission rate (CRR), overall resp...
Saved in:
| Main Authors: | Gabriel N. Mannis, Camille N. Abboud, Naval G. Daver, Guru Subramanian Guru Murthy, Eunice S. Wang, Terrence J. Bradley, George Yaghmour, Pankit Vachhani, Suresh Kumar Balasubramanian, Chong Chyn Chua, Chun Yew Fong, Adam S. Asch, Mei Dong, Shuang Li, Taravat Bagheri, Parul Doshi, Paresh Vyas, Monzr M. Al Malki |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2025-06-01
|
| Series: | eJHaem |
| Subjects: | |
| Online Access: | https://doi.org/10.1002/jha2.70051 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
HEMATOLOGICAL MALIGNANCIES. LYMPHOCYTIC LEUKAEMIA
by: Peter F. Litvitsky, et al.
Published: (2016-11-01) -
Priapism as the first presentation of chronic myeloid leukaemia in an otherwise healthy young man
by: A. F. Z. Mohamed, et al.
Published: (2025-03-01) -
Outcomes of melphalan 140 mg/m2 followed by autologous stem cell transplantation in multiple myeloma patients with co‐morbidities: Single‐centre experience
by: Dario Melotti, et al.
Published: (2024-10-01) -
Reticulin‐Free Quantitation of Bone Marrow Fibrosis in MPNs: Utility and Applications
by: Hosuk Ryou, et al.
Published: (2025-04-01) -
Challenges associated with the Management of Haematological Malignancies in sub-Saharan Africa
by: Shehu, A.R.* 1, Erhabor, O. 1, Hamid, K. 2, Umar Z.U. 2
Published: (2021-03-01)